https://www.marketscreener.com/quote/stock/ATEA-PHARMACEUTICALS-INC-114338425/news/Atea-Pharmaceuticals-Announces-First-Patient-Dosed-in-SUNRISE-3-Phase-3-Registrational-Trial-of-Bemn-42425853/?utm_source=telegram&utm_medium=social&utm_campaign=share